"Dexcom Receives FDA Approval for First Over-the-Counter Continuous Glucose Monitor"
TL;DR Summary
The FDA has approved Dexcom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor (CGM) for adults 18 and up who are not using insulin, providing a tool for managing diabetes with oral medications and for non-diabetics looking to control sugar intake. The device pairs with a smartphone app to display blood glucose measurements and trends every 15 minutes, and will be available this summer, offering a 15-day patch option for those without insurance coverage for CGM.
Topics:business#continuous-glucose-monitor#dexcom#diabetes#fda#healthtech#stelo-glucose-biosensor-system
- FDA approves the first over-the-counter continuous glucose monitor Engadget
- Dexcom's first-ever over-the-counter glucose monitor patch gets FDA clearance CNBC
- FDA Clears First OTC Continuous Glucose Monitoring, Dexcom Stelo Glucose Biosensor System Pharmacy Times
- FDA Clears Dexcom Stelo Sensor, First OTC Glucose Sensor in Agency History MD Magazine
- San Diego's Dexcom gets first FDA clearance for an over-the-counter wearable continuous glucose monitor The San Diego Union-Tribune
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
76%
322 → 78 words
Want the full story? Read the original article
Read on Engadget